Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania W Moreira, P Leprohon, M Ouellette Cell death & disease 2 (9), e201-e201, 2011 | 119 | 2011 |
Boromycin kills mycobacterial persisters without detectable resistance W Moreira, DB Aziz, T Dick Frontiers in microbiology 7, 182117, 2016 | 82 | 2016 |
Amphiphilic indole derivatives as antimycobacterial agents: structure–activity relationships and membrane targeting properties T Yang, W Moreira, SA Nyantakyi, H Chen, DB Aziz, ML Go, T Dick Journal of medicinal chemistry 60 (7), 2745-2763, 2017 | 79 | 2017 |
A macromolecule reversing antibiotic resistance phenotype and repurposing drugs as potent antibiotics X Ding, C Yang, W Moreira, P Yuan, B Periaswamy, PF de Sessions, ... Advanced Science 7 (17), 2001374, 2020 | 75 | 2020 |
Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria. W Moreira, GJ Ngan, JL Low, A Poulsen, BC Chia, MJ Ang, A Yap, ... | 71 | 2015 |
The mycobacterial membrane: a novel target space for anti-tubercular drugs H Chen, SA Nyantakyi, M Li, P Gopal, DB Aziz, T Yang, W Moreira, ... Frontiers in microbiology 9, 1627, 2018 | 50 | 2018 |
The role of reduced pterins in resistance to reactive oxygen and nitrogen intermediates in the protozoan parasite Leishmania W Moreira, É Leblanc, M Ouellette Free Radical Biology and Medicine 46 (3), 367-375, 2009 | 44 | 2009 |
Towards selective mycobacterial ClpP1P2 inhibitors with reduced activity against the human proteasome W Moreira, S Santhanakrishnan, GJY Ngan, CB Low, K Sangthongpitag, ... Antimicrobial agents and chemotherapy 61 (5), 10.1128/aac. 02307-16, 2017 | 32 | 2017 |
Hydrogen Sulfide Sensitizes Acinetobacter baumannii to Killing by Antibiotics SY Ng, KX Ong, ST Surendran, A Sinha, JJH Lai, J Chen, J Liang, ... Frontiers in Microbiology 11, 1875, 2020 | 26 | 2020 |
Fragment-Based Whole Cell Screen Delivers Hits against M. tuberculosis and Non-tuberculous Mycobacteria W Moreira, JJ Lim, SY Yeo, PM Ramanujulu, BW Dymock, T Dick Frontiers in microbiology 7, 1392, 2016 | 23 | 2016 |
Bortezomib warhead-switch confers dual activity against mycobacterial caseinolytic protease and proteasome and selectivity against human proteasome W Moreira, S Santhanakrishnan, BW Dymock, T Dick Frontiers in Microbiology 8, 746, 2017 | 22 | 2017 |
Proteomic analysis of metacyclogenesis in Leishmania infantum wild-type and PTR1 null mutant W Moreira, D Légaré, G Racine, G Roy, M Ouellette EuPA Open Proteomics 4, 171-183, 2014 | 17 | 2014 |
Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania. Cell Death Dis. 2011; 2: e201 W Moreira, P Leprohon, M Ouellette Epub 2011/09/02. https://doi. org/10. 1038/cddis. 2011.83 PMID: 21881603, 0 | 7 | |
inPhocus: current state and challenges of phage research in Singapore NK Verma, SJ Tan, J Chen, H Chen, MH Ismail, SA Rice, P Bifani, ... Therapy, Applications, and Research 3 (1), 6-11, 2022 | 2 | 2022 |
Antibiotic Resistance: A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics (Adv. Sci. 17/2020) X Ding, C Yang, W Moreira, P Yuan, B Periaswamy, PF de Sessions, ... Advanced Science 7 (17), 2070094, 2020 | 1 | 2020 |
Dipeptidyl boronates as ClpP1P2 inhibitors: A novel approach to anti tuberculosis therapy A Poulsen, P Gopal, S Santhanakrishnan, KF Jihao, C Huang, BCS Chia, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 254, 2017 | | 2017 |
Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome T Dick, W Moreira, S Santhanakrishnan, BW Dymock | | 2017 |
Bortezomib as an inhibitor of mycobacterial caseinolytic protease (clp) for treatment of tuberculosis T Dick, W MOREIRA, EJ RUBIN, R Ravikiran, C Cheng San Brian | | 2016 |
Stress oxydatif, différentiation et mort cellulaire chez le parasite Leishmania W Moreira | | 2011 |
Insertion of a Triphenylphosphonium Moiety to 1-alkyl-1H-indoles Improved Anti-mycobacterial Activity A Nyantakyi Samuel, D Aziz, W Moreira, T Dick, ML Go | | |